ASKA Pharmaceutical Holdings Co Ltd
TSE:4886

Watchlist Manager
ASKA Pharmaceutical Holdings Co Ltd Logo
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Watchlist
Price: 2 070 JPY -1.33% Market Closed
Market Cap: 58.6B JPY
Have any thoughts about
ASKA Pharmaceutical Holdings Co Ltd?
Write Note

ASKA Pharmaceutical Holdings Co Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ASKA Pharmaceutical Holdings Co Ltd
Total Liabilities & Equity Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Total Liabilities & Equity
ÂĄ90.7B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Total Liabilities & Equity
ÂĄ16.2T
CAGR 3-Years
9%
CAGR 5-Years
4%
CAGR 10-Years
14%
Daiichi Sankyo Co Ltd
TSE:4568
Total Liabilities & Equity
ÂĄ3.4T
CAGR 3-Years
19%
CAGR 5-Years
11%
CAGR 10-Years
7%
Otsuka Holdings Co Ltd
TSE:4578
Total Liabilities & Equity
ÂĄ3.7T
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
6%
Chugai Pharmaceutical Co Ltd
TSE:4519
Total Liabilities & Equity
ÂĄ1.9T
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
10%
Astellas Pharma Inc
TSE:4503
Total Liabilities & Equity
ÂĄ3.7T
CAGR 3-Years
18%
CAGR 5-Years
14%
CAGR 10-Years
9%

See Also

What is ASKA Pharmaceutical Holdings Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
90.7B JPY

Based on the financial report for Mar 31, 2024, ASKA Pharmaceutical Holdings Co Ltd's Total Liabilities & Equity amounts to 90.7B JPY.

What is ASKA Pharmaceutical Holdings Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
2%

Over the last year, the Total Liabilities & Equity growth was 4%. The average annual Total Liabilities & Equity growth rates for ASKA Pharmaceutical Holdings Co Ltd have been 3% over the past three years , 2% over the past five years .

Back to Top